Showing 81 - 100 of 155 results
Stephen Wilkins Medal
Applications open for 2017 ANSTO Australian Synchrotron Stephen Wilkins Medal
2017 ANSTO, Australian Synchrotron Stephen Wilkins Medal
Nominations are being accepted for the 2017 Stephen Wilkins medal for an outstanding thesis.
Australian led cancer project making an impact at its first regional training course in Malaysia
The Australian led regional cancer care project in medical physics held its first regional training course in Malaysia to progress Rays of Hope.
Repatriation of Australian waste from France
Australian grads defy exodus for chance to work in science
Statement of Expectations
On the 10th of October 2025, the Minister for Industry, Science and Technology provided his Statement of Expectations to ANSTO.
Teachers Down Under Head to CERN: Australian Educators Selected for International High School Teacher Program
Part of the Large Hardon Collider
Study of polar ice confirms carbon-climate feedback
Investigators have verified and quantified the relationship between the Earth’s land biosphere and changes in temperature and provided evidence that temperature impacts the cycling of carbon between land, ocean and the atmosphere.
Role at ANSTO
Studies in selective microbial deuteration for chiral molecules
‘Atomic chicken-wire’ is key to faster DNA sequencing
An unusual and very exciting form of carbon - that can be created by drawing on paper - looks to hold the key to real-time, high throughput DNA sequencing, a technique that would revolutionise medical research and testing.
ANSTO Staff gear up for Sutherland2Surf
ANSTO-University of Wollongong Joint Project Seed Funding
Role at ANSTO
Transport revolution on the horizon following discovery of ‘stainless magnesium’
Distinguished researchers who use synchrotron techniques recognised
Synchrotron technique reveals more details of mysterious underlying portrait in Renaissance painting held by Art Gallery of NSW
Remarkable clinical trial results shared internationally
A targeted radioactive infusion that is a game-changer in late-stage prostate cancer can also dramatically improve outcomes for patients in earlier stages of this disease, a Peter Mac-led study has shown.